ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Glioma
Brain Cancer
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Dallas, TX, USA:

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...

Enrolling
Glioblastoma
Device: Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Phase 4

GT Medical Technologies

Dallas, Texas, United States and 13 other locations

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

Dallas, Texas, United States and 61 other locations

This multi-site, Phase 1/2a clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen o...

Enrolling
Glioblastoma Multiforme
Drug: Perillyl alcohol

Phase 1, Phase 2

NeOnc Technologies

Dallas, Texas, United States and 7 other locations

are also impermeable to the passage of therapeutic molecules from the blood to the brain. The development of effective treatments against glioblastoma...

Enrolling
Glioblastoma
Recurrent Glioblastoma
Device: SonoCloud-9 (SC9)
Drug: Temozolomide

Phase 3

Carthera

Dallas, Texas, United States and 27 other locations

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting
Glioblastoma Multiforme
Device: Optune®
NovoCure
NovoCure

Dallas, Texas, United States and 132 other locations

receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM) expr...

Enrolling
Advanced Non-Small Cell Squamous Lung Cancer
Epidermal Growth Factor Receptor C797S
Drug: BDTX-1535 monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Dallas, Texas, United States and 24 other locations

This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given...

Enrolling
Glioma
Drug: Rhenium Liposome Treatment

Phase 1, Phase 2

Plus Therapeutics

Dallas, Texas, United States and 2 other locations

The purpose of this study is to examine the effects of Tofacitinib in patients with recurrent Glioblastoma....

Enrolling
Glioblastoma
Drug: Tofacitinib 10mg

Phase 3

The University of Texas System (UT)
The University of Texas System (UT)

Dallas, Texas, United States

This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...

Active, not recruiting
Glioblastoma Multiforme, Adult
Drug: Berubicin
Drug: Lomustine

Phase 2

CNS Pharmaceuticals
CNS Pharmaceuticals

Dallas, Texas, United States and 47 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems